Delivery Order SPE2DX22D0129-SPE2D826F0DCJ
- Not listed
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $150,760.44 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by January 13, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,130.75 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of January 13, 2026 and involves no set-aside designation. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $60,112.64 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 13, 2026. This firm fixed-price delivery order was issued under a competitive, non-set-aside procurement and will be performed at the company's Conshohocken, Pennsylvania facility. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,525.30 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is to be performed in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates as a subsidiary of parent...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at approximately $1.02 million to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 8, 2026. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle. The contractor is headquartered in Conshohocken, Pennsylvania, the same location designated as the place of performance, and operates as a subsidiary of...
- On January 9, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,041.77 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,157.06 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,584.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by January 13, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded and represents a routine...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,665.95 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The contract is performed out of the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a task order...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DCJDelivery Order
On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $128,662.52 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract supports critical medical commodity needs for military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $128.7k | 1/11/26 |